Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
David Moenning's Daily State of the Markets: 7/21
-
Pre-Open Movers 7/21: Genentech (DNA) Higher on Bid for Roche; BofA (BAC) Up on Results
-
Deutsche Bank Boosts Price Target on Genentech (DNA) to $85
-
Deutsche Bank Starts Genentech (DNA) at Buy
-
Deutsche Bank Starts Coverage on Large Biotechs; DNA, GILD & AMGN Rated Buys, BIIB & GENZ Rated Holds
-
David Moenning's Daily State of the Markets: 2/25
-
Pre-Open Movers 2/25: Take-Two (TTWO) Soars On Offer from EA, Getty Images (GYI) Up on Buyout
-
David Moenning's Daily State of the Markets:
-
David Moenning’s Daily State of the Markets: 01/15
-
Pre-Open Movers: MoneyGram (MGI) Sinks On Investment Losses, Manatron (MANA), Lifecore Biomedical (LCBM) Up on Buyouts
